BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 5283931)

  • 1. Regulation of formation and proposed structure of the factor inhibiting the release of melanocyte-stimulating hormone.
    Celis ME; Taleisnik S; Walter R
    Proc Natl Acad Sci U S A; 1971 Jul; 68(7):1428-33. PubMed ID: 5283931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum MSH levels and the hypothalamic enzymes involved in the formation of MSH-RF during the estrous cycle in the rat.
    Celis ME
    Neuroendocrinology; 1975; 18(3):256-62. PubMed ID: 810734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the release of melanocyte-stimulating hormone in vitro by rat pituitary glands collected at various times during the oestrous cycle.
    Vivas A; Celis ME
    J Endocrinol; 1978 Jul; 78(1):1-6. PubMed ID: 567239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of MSH release in frogs by direct application of L-proplyl-L-leucylglycinamide to the pituitary.
    Kastin AJ; Schally AV; Viosca S
    Proc Soc Exp Biol Med; 1971 Sep; 137(4):1437-9. PubMed ID: 5316453
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of MSH release-inhibiting elements in the neurointermediate lobe of the rat.
    Tilders FJ; van der Woude HA; Swaab DF; Mulder AH
    Brain Res; 1979 Aug; 171(3):425-35. PubMed ID: 38880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic peptides involved in the control of MSH secretion: identity, biosynthesis and regulation of their release.
    Celis ME
    Front Horm Res; 1977; 4():69-79. PubMed ID: 26616
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro formation of a MSH-releasing agent by hypothalamic extracts.
    Celis ME; Taleisnik S
    Experientia; 1971 Dec; 27(12):1481-2. PubMed ID: 5144873
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence that Pro-Leu-Gly-NH 2 , tocinoic acid, and des-Cys-tocinoic acid do not affect secretion of melanocyte stimulating hormone.
    Grant NH; Clark DE; Rosanoff EI
    Biochem Biophys Res Commun; 1973 Mar; 51(1):100-6. PubMed ID: 4540644
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in hypothalamic and pituitary content of immunoreactive alpha-melanocyte-stimulating hormone during the gestational and postpartum periods in the rat.
    Khorram O; DePalatis LR; McCann SM
    Proc Soc Exp Biol Med; 1984 Nov; 177(2):318-26. PubMed ID: 6483865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The failure of L-prolyl-L-leucylglycinamide to inhibit the release of alpha-melanocyte-stimulating hormone in the rat.
    Thody AJ; Lever de Vries CH; Tilders FJ
    Acta Endocrinol (Copenh); 1980 Mar; 93(3):300-5. PubMed ID: 6103629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen influence on the hypothalamic enzymes involved in the formation of melanocyte-stimulating hormone release-inhibiting factor (MSH-R-IF).
    Celis ME; Taleisnik S
    Proc Soc Exp Biol Med; 1974 Jan; 145(1):142-4. PubMed ID: 4591390
    [No Abstract]   [Full Text] [Related]  

  • 12. Pituitary content of oxytocin, vasopressin and alpha-melanocyte-stimulating hormone in the fetus of the rat during labour.
    Boer K; Dogterom J; Pronker HF
    J Endocrinol; 1980 Aug; 86(2):221-9. PubMed ID: 7430891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurohypophyseal hormone fragment-induced release of MSH.
    Celis ME; Vivas A; Orlowski RC; Walter R
    Brain Res; 1978 Jun; 149(2):516-8. PubMed ID: 667612
    [No Abstract]   [Full Text] [Related]  

  • 14. Release of pituitary melanocyte-stimulating hormone by the oxytocin fragment, H-Cys-Tyr-Ile-Gln-Asn-Oh.
    Celis ME; Taleisnik S; Walter R
    Biochem Biophys Res Commun; 1971 Nov; 45(3):564-9. PubMed ID: 4942720
    [No Abstract]   [Full Text] [Related]  

  • 15. Melanophore stimulating hormone: release inhibition by ring structures of neurohypophysial hormones.
    Hruby VJ; Smith CW; Bower A; Hadley ME
    Science; 1972 Jun; 176(4041):1331-2. PubMed ID: 4624585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative MSH release-inhibiting activities of tocinoic acid (the ring of oxytocin), and L-pro-L-leu-gly-NH 2 (the side chain of oxytocin).
    Bower A; Hadley ME; Hruby VJ
    Biochem Biophys Res Commun; 1971 Dec; 45(5):1185-91. PubMed ID: 5135504
    [No Abstract]   [Full Text] [Related]  

  • 17. General activity in intact and hypophysectomized rats after administration of melanocyte-stimulating hormone (MSH), melatonin, and PRO-LEU-GLY-NH 2 .
    Kastin AJ; Miller MC; Ferrell L; Schally AV
    Physiol Behav; 1973 Feb; 10(2):399-401. PubMed ID: 4575310
    [No Abstract]   [Full Text] [Related]  

  • 18. A diurnal rhythm in melanocyte-stimulating hormone content of the rat pituitary gland and its independence from the pineal gland.
    Tilders FJ; Smelik PG
    Neuroendocrinology; 1975; 17(4):296-308. PubMed ID: 1079927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ability of various factors to oppose the stimulatory effect of dibutyrylcyclic AMP on the release of melanocyte-stimulating hormone by the rat pituitary in vitro.
    Baker BI
    J Endocrinol; 1976 Feb; 68(02):283-7. PubMed ID: 176294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and structure of another hypothalamic peptide possessing MSH-release-inhibiting activity.
    Nair RM; Kastin AJ; Schally AV
    Biochem Biophys Res Commun; 1972 Jun; 47(6):1420-5. PubMed ID: 5040241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.